First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

NCT05875168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Metastatic Solid Tumor

Interventions

DRUG: DS-3939a

Sponsor

Daiichi Sankyo